Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Pluripotent hybrid stem cells from transgenic Huntington's disease monkey.

Laowtammathron C, Chan AW.

Methods Mol Biol. 2013;1010:61-77. doi: 10.1007/978-1-62703-411-1_5.

PMID:
23754219
2.

Monkey hybrid stem cells develop cellular features of Huntington's disease.

Laowtammathron C, Cheng ECh, Cheng PH, Snyder BR, Yang SH, Johnson Z, Lorthongpanich C, Kuo HC, Parnpai R, Chan AW.

BMC Cell Biol. 2010 Feb 5;11:12. doi: 10.1186/1471-2121-11-12.

3.

Germline transmission in transgenic Huntington's disease monkeys.

Moran S, Chi T, Prucha MS, Ahn KS, Connor-Stroud F, Jean S, Gould K, Chan AW.

Theriogenology. 2015 Jul 15;84(2):277-85. doi: 10.1016/j.theriogenology.2015.03.016. Epub 2015 Mar 25.

4.

Reprogramming Huntington monkey skin cells into pluripotent stem cells.

Chan AW, Cheng PH, Neumann A, Yang JJ.

Cell Reprogram. 2010 Oct;12(5):509-17. doi: 10.1089/cell.2010.0019.

5.

Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.

Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, Song H.

Mol Brain. 2012 May 21;5:17. doi: 10.1186/1756-6606-5-17.

6.

The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.

Camnasio S, Delli Carri A, Lombardo A, Grad I, Mariotti C, Castucci A, Rozell B, Lo Riso P, Castiglioni V, Zuccato C, Rochon C, Takashima Y, Diaferia G, Biunno I, Gellera C, Jaconi M, Smith A, Hovatta O, Naldini L, Di Donato S, Feki A, Cattaneo E.

Neurobiol Dis. 2012 Apr;46(1):41-51. doi: 10.1016/j.nbd.2011.12.042.

PMID:
22405424
7.

miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models.

Cheng PH, Li CL, Chang YF, Tsai SJ, Lai YY, Chan AW, Chen CM, Yang SH.

Am J Hum Genet. 2013 Aug 8;93(2):306-12. doi: 10.1016/j.ajhg.2013.05.025. Epub 2013 Jun 27.

8.

Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.

Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS, Choi NJ, Park BC, Kang SH, Ryu J, Oh SH, Shin DA, Lee DR, Do JT, Park IH, Daley GQ, Song J.

Biochem J. 2012 Sep 15;446(3):359-71. doi: 10.1042/BJ20111495.

PMID:
22694310
9.

Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.

Carter RL, Chen Y, Kunkanjanawan T, Xu Y, Moran SP, Putkhao K, Yang J, Huang AH, Parnpai R, Chan AW.

Stem Cell Reports. 2014 Oct 14;3(4):585-93. doi: 10.1016/j.stemcr.2014.07.011. Epub 2014 Sep 4.

10.

Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells.

Zhu WZ, Van Biber B, Laflamme MA.

Methods Mol Biol. 2011;767:419-31. doi: 10.1007/978-1-61779-201-4_31.

11.

Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.

Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J, Shim SH, Choi C, Chang DJ, Kwon J, Oh SH, Shin DA, Kim HS, Do JT, Lee DR, Kim M, Kang KS, Daley GQ, Brundin P, Song J.

Stem Cells. 2012 Sep;30(9):2054-62. doi: 10.1002/stem.1135. Erratum in: Stem Cells. 2012 Nov;30(11):2602.

12.

Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease.

El-Akabawy G, Rattray I, Johansson SM, Gale R, Bates G, Modo M.

BMC Neurosci. 2012 Aug 9;13:97. doi: 10.1186/1471-2202-13-97.

13.

A two years longitudinal study of a transgenic Huntington disease monkey.

Chan AW, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J, Chi T, Moran S, Engelhardt H, Larkin K, Neumann A, Cheng H, Li C, Nelson K, Banta H, Zola SM, Villinger F, Yang J, Testa CM, Mao H, Zhang X, Bachevalier J.

BMC Neurosci. 2014 Mar 3;15:36. doi: 10.1186/1471-2202-15-36.

14.

Modeling Huntington's disease with induced pluripotent stem cells.

Kaye JA, Finkbeiner S.

Mol Cell Neurosci. 2013 Sep;56:50-64. doi: 10.1016/j.mcn.2013.02.005. Epub 2013 Feb 28. Review.

15.

Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.

Ojala M, Rajala K, Pekkanen-Mattila M, Miettinen M, Huhtala H, Aalto-Setälä K.

PLoS One. 2012;7(10):e48659. doi: 10.1371/journal.pone.0048659. Epub 2012 Oct 31.

16.

Homologous feeder cells support undifferentiated growth and pluripotency in monkey embryonic stem cells.

Li T, Wang S, Xie Y, Lu Y, Zhang X, Wang L, Yang S, Wolf D, Zhou Q, Ji W.

Stem Cells. 2005 Sep;23(8):1192-9. Epub 2005 Jun 13.

17.

Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.

Castiglioni V, Onorati M, Rochon C, Cattaneo E.

Neurobiol Dis. 2012 Apr;46(1):30-40. doi: 10.1016/j.nbd.2011.12.032. Epub 2011 Dec 28.

PMID:
22227000
18.

Transgenic Animal Models of Huntington's Disease.

Yang SH, Chan AW.

Curr Top Behav Neurosci. 2011;7:61-85. doi: 10.1007/7854_2010_105.

PMID:
21225414
19.

Generation of green fluorescent protein-expressing monkey embryonic stem cells.

Takada T, Suzuki Y, Kadota N, Kondo Y, Torii R.

Methods Mol Biol. 2006;329:305-12.

PMID:
16846000
20.

How can human pluripotent stem cells help decipher and cure Huntington's disease?

Perrier A, Peschanski M.

Cell Stem Cell. 2012 Aug 3;11(2):153-61. doi: 10.1016/j.stem.2012.07.015.

Items per page

Supplemental Content

Write to the Help Desk